GNH USA

Europe — EMA

Migsun (Naproxen Sodium, Sumatriptan Succinate)

GNH USA supplies Migsun (naproxen/sumatriptan), an NSAID and 5‑HT1B/1D agonist for acute migraine treatment. Request a quote for global worldwide supply.

Naproxen Sodium, Sumatriptan Succinate

Request sourcing

1
Pack/s

What is Naproxen Sodium, Sumatriptan Succinate?

Naproxen sodium and sumatriptan succinate, the active ingredients in Migsun, are an NSAID and 5‑HT1B/1D agonist combination presented as an oral tablet for oral use. It treats acute migraine attacks in adults.

GNH USA supplies Migsun as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Naproxen Sodium, Sumatriptan Succinate used for?

Migsun, a combined NSAID and 5‑HT1B/1D agonist, is indicated for the acute treatment of migraine. - Migraine without aura: provides rapid relief of headache pain and associated symptoms such as nausea and photophobia. - Migraine with aura: reduces headache intensity and helps resolve visual disturbances. - Acute migraine attack: shortens the duration of the attack and improves functional ability.

What are the side effects of Naproxen Sodium, Sumatriptan Succinate?

Common Side Effects: - Nausea: mild stomach upset. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation. - Fatigue: feeling of tiredness. - Chest discomfort: mild pressure in the chest. Serious or Rare Side Effects: - Cardiovascular events: rare myocardial infarction or stroke. - Severe allergic reaction: anaphylaxis or angioedema. - Serotonin syndrome: rare but potentially life‑threatening when combined with other serotonergic drugs.

What precautions apply to Naproxen Sodium, Sumatriptan Succinate?

Before using Migsun, consider the following precautions: - Medical history: assess for cardiovascular disease, hypertension, or liver/kidney impairment. - Concomitant medications: review use of other serotonergic agents, anticoagulants, or NSAIDs. - Renal function: use with caution in patients with reduced renal clearance. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Store at ambient temperature: keep in the original pack, protect from moisture.

What does Naproxen Sodium, Sumatriptan Succinate interact with?

Migsun may interact with several medicines. Major Interactions (Avoid): - MAO inhibitors: increased risk of serotonin syndrome. - SSRIs, SNRIs, or other triptans: additive serotonergic effects. - Ergot derivatives: severe vasospasm. - Certain antihypertensives: may enhance vasoconstriction. Moderate Interactions (Monitor Closely): - Anticoagulants or antiplatelet drugs: heightened bleeding risk. - Diuretics: may affect renal clearance of naproxen. - Lithium: possible increase in lithium serum levels.

Frequently asked questions

What is Migsun used for?+
Migsun is a prescription oral tablet that combines naproxen sodium, an NSAID, with sumatriptan succinate, a selective 5‑HT1B/1D receptor agonist. The combination is indicated for the acute treatment of migraine attacks in adults, providing both anti‑inflammatory pain relief and cranial vasoconstriction to alleviate headache and associated symptoms such as nausea, photophobia, and phonophobia.
How does naproxen sodium/sumatriptan work?+
Naproxen sodium inhibits cyclo‑oxygenase enzymes COX‑1 and COX‑2, reducing prostaglandin synthesis and inflammation that contribute to pain. Sumatriptan succinate selectively activates 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings, causing vasoconstriction and blocking release of pro‑inflammatory neuropeptides. Together they address both vascular and inflammatory components of a migraine attack.
What is the usual dose?+
The specific dose and dosing schedule of Migsun are determined by the prescribing healthcare professional based on the individual’s clinical condition, severity of migraine, and any concomitant medications. Patients should follow the prescriber’s instructions and the product labeling, and should not adjust the dose without medical advice.
Is Migsun safe in pregnancy or breastfeeding?+
Safety of Migsun during pregnancy or lactation has not been fully established. Naproxen sodium is generally avoided in the third trimester because of potential fetal cardiovascular effects, and sumatriptan is classified as pregnancy category C in many regions. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their physician before using this medication.
How do I order Migsun from GNH USA?+
To place an order, visit the product page for Migsun on the GNH USA website (gnh-usa.com), enter the required quantity, and submit the enquiry form. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide; the sales team will verify institutional credentials, then provide pricing, availability, shipping details (including any temperature‑controlled logistics), and assist with import documentation.
How does Migsun compare with other migraine treatments?+
Compared with single‑agent triptans, Migsun adds an NSAID component, which can enhance pain relief, reduce the need for additional analgesics, and potentially lower the risk of recurrence. Relative to NSAID‑only therapy, the sumatriptan component provides targeted vasoconstriction, addressing the vascular component of migraine. Clinical studies suggest the combination may achieve faster and more sustained headache relief than either component alone.
How should Migsun be stored and handled?+
Migsun tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiration date printed on the label. No special refrigeration is required.
How is Migsun administered?+
Migsun is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not crushed, chewed, or broken, unless otherwise directed by a healthcare professional. It is typically taken at the onset of a migraine attack, and patients should follow the dosing instructions provided by their prescriber.
What are the most serious risks associated with Migsun?+
The most serious risks include cardiovascular events such as myocardial infarction or stroke, particularly in patients with pre‑existing heart disease, and serotonin syndrome when combined with other serotonergic agents. Severe allergic reactions, including anaphylaxis, can also occur. Patients should seek immediate medical attention if they experience chest pain, rapid heartbeat, severe dizziness, or signs of an allergic reaction.
Who should not use Migsun?+
Migsun is contraindicated in individuals with known hypersensitivity to naproxen, sumatriptan, or any component of the formulation. It should not be used by patients with uncontrolled hypertension, recent ischemic heart disease, severe hepatic or renal impairment, or those taking monoamine oxidase inhibitors within the past 14 days. Pregnant women in the third trimester and patients with certain vascular disorders should also avoid this medication.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Naproxen Sodium, Sumatriptan Succinate
Route
Oral Use
Manufacturer
Orion Corporation
Origin
EU

Related products

Frimig Duo

Frimig Duo

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU
Frimig Duo

Frimig Duo

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU
Frimig Duo

Frimig Duo

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU
Migsun

Migsun

Naproxen Sodium, Sumatriptan Succinate

Orion Corporation
EU